
Benzinga Pro data, Bionano Genomics (NASDAQ:BNGO) reported Q4 sales of $6.30 million. Earnings fell to a loss of $22.95 million, resulting in a 10.58% decrease from last quarter. Bionano Genomics collected $4.66 million in revenue during Q3, but reported earnings showed a $20.75 million loss.